A CONVENIENT PREFILLED, NO-MIX SYRINGE FOR GnRH AGONIST TREATMENT OF ADVANCED PROSTATE CANCER IN ADULTS
CAMCEVI® is the first sub-Q leuprolide that comes prefilled with no mixing. In an open-label, single-arm study of 137 adults who received 42 mg of CAMCEVI on Day 0 and Week 24, CAMCEVI offered consistent testosterone suppression to castrate levels, after the initial injection, from Week 4 to Week 48.1See how simple syringe prep can be
CAMCEVI offers proven leuprolide efficacy in a convenient prefilled,
CAMCEVI comes prefilled with no mixing required—simplifying syringe prep for you.1Learn more about dosing
Access useful resources, information, and more for you and your patients.See all resources
Order CAMCEVI through your distribution and GPO partners.Learn more
HAVE A QUESTION?
Let us simplify it for you.CONNECT WITH A REPRESENTATIVE